Sanofi Drug Patent Portfolio

Sanofi owns 2 orange book drugs protected by 10 US patents Given below is the list of Sanofi's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7985418 Aliphatic amine polymer salts for tableting 27 Oct, 2025
Active
US7148211 Formulation for lipophilic agents 14 Sep, 2023 Expired
US6903083 Stabilized hydroxyvitamin D 18 Jul, 2021 Expired
US5667775 Phosphate-binding polymers for oral administration 16 Sep, 2014 Expired
US5602116 Method for treating and preventing secondary hyperparathyroidism 11 Feb, 2014 Expired
US5496545 Phosphate-binding polymers for oral administration 11 Aug, 2013 Expired
US6509013 Method of making phosphate-binding polymers for oral administration 11 Aug, 2013 Expired
US6858203 Method of making phosphate-binding polymers for oral administration 11 Aug, 2013 Expired
US7014846 Phosphate-binding polymers for oral administration 11 Aug, 2013 Expired
US7459151 Phosphate-binding polymers for oral administration 11 Aug, 2013 Expired


Given below is the list of recent legal activities going on the following drug patents of Sanofi.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 8th Year, Large Entity 18 Jan, 2023 US9095509
Payment of Maintenance Fee, 12th Year, Large Entity 11 Jan, 2023 US7985418
Payment of Maintenance Fee, 12th Year, Large Entity 21 May, 2020 US7459151
Payment of Maintenance Fee, 4th Year, Large Entity 24 Jan, 2019 US9095509
Payment of Maintenance Fee, 8th Year, Large Entity 10 Jan, 2019 US7985418
Payment of Maintenance Fee, 12th Year, Large Entity 31 May, 2018 US7148211 (Litigated)
Recordation of Patent Grant Mailed 04 Aug, 2015 US9095509
Patent Issue Date Used in PTA Calculation 04 Aug, 2015 US9095509
Issue Notification Mailed 15 Jul, 2015 US9095509
Application Is Considered Ready for Issue 07 Jul, 2015 US9095509
Dispatch to FDC 07 Jul, 2015 US9095509
Mailing Corrected Notice of Allowability 06 Jul, 2015 US9095509
Printer Rush- No mailing 06 Jul, 2015 US9095509
Corrected Notice of Allowability 02 Jul, 2015 US9095509
Issue Fee Payment Verified 25 Jun, 2015 US9095509


Sanofi's Family Patents

Sanofi drugs have patent protection in a total of 17 countries. It's US patent count contributes only to 25.0% of its total global patent coverage. 2 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Sanofi Drug List

Given below is the complete list of Sanofi's drugs and the patents protecting them.


1. Hectorol

Hectorol is protected by 3 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7148211 Formulation for lipophilic agents 14 Sep, 2023
(1 year, 1 month ago)
Expired
US6903083 Stabilized hydroxyvitamin D 18 Jul, 2021
(3 years ago)
Expired
US5602116 Method for treating and preventing secondary hyperparathyroidism 11 Feb, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Hectorol's drug page


2. Renvela

Renvela is protected by 7 patents, out of which 6 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7985418 Aliphatic amine polymer salts for tableting 27 Oct, 2025
(1 year, 12 days from now)
Active
US5667775 Phosphate-binding polymers for oral administration 16 Sep, 2014
(10 years ago)
Expired
US5496545 Phosphate-binding polymers for oral administration 11 Aug, 2013
(11 years ago)
Expired
US6509013 Method of making phosphate-binding polymers for oral administration 11 Aug, 2013
(11 years ago)
Expired
US6858203 Method of making phosphate-binding polymers for oral administration 11 Aug, 2013
(11 years ago)
Expired
US7014846 Phosphate-binding polymers for oral administration 11 Aug, 2013
(11 years ago)
Expired
US7459151 Phosphate-binding polymers for oral administration 11 Aug, 2013
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Renvela's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Sanofi News

Contamination problems discovered by FDA at Thermo Fisher facility in North Carolina - Fierce Pharma

11 Oct, 2024

Developer of Zantac agrees to settle lawsuits alleging a connection to cancer, reports The New York Times

10 Oct, 2024

FDA Approves Dupixent, a Biologic Drug by Sanofi and Regeneron, for COPD Treatment

29 Sep, 2024

FDA approves Dupixent for COPD, developed by Regeneron and Sanofi - Fierce Pharma

27 Sep, 2024

See More